Allergan Sells Dermatology Drugs To Almirall For $650M
Allergan PLC has agreed to sell five of its dermatology products to Spanish drugmaker Almirall SA in a deal worth up to $650 million, the European company announced Friday....To view the full article, register now.
Already a subscriber? Click here to view full article